Breaking News
4 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Anupam Rasayan acquires a 43.3–48.2% stake in Bliss GVS Pharma, raising GMP alignment and regulatory integration questions for the combined entity.
Pharma Now Editorial Team

AbbVie's MAVIRET receives CHMP positive opinion for acute HCV, potentially creating one of the EU's few dual acute/chronic hepatitis C labels.
Pharma Now Editorial Team

Lilly's Foundayo hit statistically significant weight loss across all doses at 72 weeks, raising CMC and scale-up stakes for oral GLP-1 competitors.
Pharma Now Editorial Team

CHMP backs Merck's KEYTRUDA combo for bladder cancer; European Commission decision expected Q3 2026.
Pharma Now Editorial Team
